Le Lézard
Classified in: Health, Covid-19 virus
Subjects: CSR, SCZ

Emergency Telehealth Initiative For Assisted Living Facilities


SARASOTA, Fla., March 17, 2020 /PRNewswire/ -- During the coronavirus crisis, our nation's top doctors urge older adults, the most vulnerable, to avoid crowded medical facilities and first consult a doctor virtually if they feel sick. As senior living communities move to limit residents' exposure to Coronavirus (COVID-19), Q Tablet for Telehealth is being deployed to independent and assisted living communities across America to help older adults receive non-emergency care while avoiding risky trips to the doctor's office or hospital.

Florida-based Constant Companion, a voice and video technology company, announced it will make these Q Tablets available to senior living communities anywhere in the U.S. for a minimal monthly cost. The tablets give the residents and nursing staff secure access to non-emergency care from the comfort and safety of their rooms. The Q Tablet for Telehealth may be rented for a cost of $25 per month including cellular high-speed internet.

The secure, high-speed Q Tablet for Telehealth is pre-loaded with apps from top-rated telemedicine providers, allowing U.S. Board-Certified doctors to make "video house calls" and write prescriptions. Constant Companion will begin shipping the tablets nationwide this week.

"This is a critical time for the health of our nation's seniors, and we are the technology partner for America's assisted living facilities from coast-to-coast," said Mark Gray, CEO and founder of Constant Companion, LLC. "As the infection rate of COVID-19 continues to grow, we are committed to protect residents and staff members in senior care, so they stay safe. We are proud we can move quickly and provide potentially life-saving devices." Any profits from the device rentals will be donated to charity by the company.

Consider this:

The Q Tablet for Telehealth:

With questions please call:

Kim Chomiak, Marketing & Media Manager
Constant Companion, LLC
Care is Always There
Tel: 941.877.4000 ext. 110
Email: [email protected]

About Constant Companion - Constant Companion utilizes voice technology and video to create engaging experiences for older adults and senior communities. The company's mission is to make people's lives better by increasing connection and protection. Constant Companion's systems are supported by advanced security to protect privacy and professional monitoring 24/7 that is voice activated eliminating the need for wearable devices. The company protects individuals living alone and partners with home care providers and assisted living facilities in approximately 200 cities nationwide.

Headquartered in Sarasota, FL, Constant Companion may be reached at 941.877.4000 or by email [email protected]. Visit online at www.ConstantCompanion.com/telehealth.

Media contacts:
Kim Chomiak [email protected] 941.877.4000 ext.110
Sue Yannello [email protected] 919.459.8162

SOURCE Constant Companion


These press releases may also interest you

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...

at 10:49
Sustain Exchange LLC is proud to announce a partnership with HearMe, a leading behavioral health peer support platform focused on ensuring healthy lives and promoting well-being. As part of this innovative partnership, SustainAble Exchange will...

at 10:45
C?N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a partnership agreement with Mediford Corporation, a PHC Holdings Corporation (TSE 6523) Group Company and premier...

at 10:35
BeiGene, Ltd. , a global oncology company, released its 2023 Responsible Business & Sustainability Report highlighting the Company's strategy, the progress it has made towards existing goals, and how it intends to achieve its bold new targets. This...

at 10:30
Invensify, Inc., Santa Clara, California, has introduced a power efficient, temperature-controlled shipping container designed to maintain stable storage temperatures for high-value pharmaceuticals before and during transport to last-mile cold chain...

at 10:30
Oligonucleotide Synthesis Market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029 according to a new report by MarketsandMarketstm. One of...



News published on and distributed by: